Arnauld Villers

32.1k total citations · 6 hit papers
339 papers, 12.8k citations indexed

About

Arnauld Villers is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Arnauld Villers has authored 339 papers receiving a total of 12.8k indexed citations (citations by other indexed papers that have themselves been cited), including 273 papers in Pulmonary and Respiratory Medicine, 82 papers in Surgery and 73 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Arnauld Villers's work include Prostate Cancer Diagnosis and Treatment (190 papers), Prostate Cancer Treatment and Research (171 papers) and Urologic and reproductive health conditions (61 papers). Arnauld Villers is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (190 papers), Prostate Cancer Treatment and Research (171 papers) and Urologic and reproductive health conditions (61 papers). Arnauld Villers collaborates with scholars based in France, United States and United Kingdom. Arnauld Villers's co-authors include Philippe Puech, Fuad S. Freiha, John E. McNeal, L. Lemaître, Xavier Leroy, Thomas A. Stamey, Mark Emberton, Elise A. Redwine, A. Ouzzane and Samir S. Taneja and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Arnauld Villers

326 papers receiving 12.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer

2019 686 citations Arnauld Villers, Neal D. Shore et al. profile →
Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature

2015 613 citations Jurgen J. Fütterer, Mark Emberton et al. profile →
Magnetic Resonance Imaging for the Detection, Localisation, and Characterisation of Prostate Cancer: Recommendations from a European Consensus Meeting

2010 555 citations Jurgen J. Fütterer, Philippe Puech et al. profile →
Image-Guided Prostate Biopsy Using Magnetic Resonance Imaging–Derived Targets: A Systematic Review

2012 411 citations Caroline M. Moore, Arnauld Villers et al. profile →
Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer

2022 169 citations Arnauld Villers, Neal D. Shore et al. profile →
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer

2023 114 citations Stephen J. Freedland, Ugo De Giorgi et al. profile →

Peers

Countries citing papers authored by Arnauld Villers

Since Specialization

Citations

This map shows the geographic impact of Arnauld Villers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnauld Villers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnauld Villers more than expected).

Fields of papers citing papers by Arnauld Villers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnauld Villers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnauld Villers. The network helps show where Arnauld Villers may publish in the future.

Co-authorship network of co-authors of Arnauld Villers

This figure shows the co-authorship network connecting the top 25 collaborators of Arnauld Villers. A scholar is included among the top collaborators of Arnauld Villers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnauld Villers. Arnauld Villers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	New kids on the block: MRI guided transrectal focused US, TULSA, focal laser ablation, histotripsy – a comprehensive review 2025 ·Prostate Cancer and Prostatic Diseases ·Sangeet Ghai, Tiffany Ni, Christian P. Pavlovich, Jurgen J. Fütterer, George R. Schade, Rafael Sánchez-Salas, F. Cornud, Scott Eggener, John F. Feller, Arvin K. George, Arnauld Villers, Jean de la Rosette	1
2	Enzalutamide in patients with high-risk biochemically recurrent prostate cancer according to the European Association of Urology definition: a post hoc analysis of EMBARK 2025 ·Prostate Cancer and Prostatic Diseases ·Ugo De Giorgi, Stephen J. Freedland, Antti Rannikko, M. Backhaus, Arnauld Villers, Jamal Tarazi, Yiyun Tang, Gabriel P. Haas, Matt Rosales, Neal D. Shore	1
3	Long-term oncological outcomes of active surveillance for low-risk prostate cancer diagnosed during the MRI era 2024 ·PubMed ·(unknown), (unknown), Philippe Puech, Xavier Leroy, (unknown), Hélène Behal, Arnauld Villers, Jonathan Olivier	1
4	Sedation vs. general anesthesia in stone ureteroscopy: Comparison of efficacy and safety, a post COVID-19 report 2024 ·PubMed ·(unknown), (unknown), (unknown), (unknown), (unknown), Gilles Lebuffe, Arnauld Villers, Gautier Marcq	0
5	P2-06 HIFI TRIAL: HIFU VS RADICAL PROSTATECTOMY FOR LOCALIZED PROSTATE CANCER IN 3328 CASES. FINAL RESULTS 2024 ·The Journal of Urology ·P. Rischmann, P. Coloby, Thierry Chevallier, Nadine Houédé, Arnauld Villers, Guillaume Ploussard	1
6	Intratumoural immunotherapy plus focal thermal ablation for localized prostate cancer 2023 ·Nature Reviews Urology ·(unknown), (unknown), Srinath Kotamarti, (unknown), (unknown), (unknown), Jonathan Olivier, Arnauld Villers, Christopher Hoimes, (unknown)	13
7	Fascin-1 expression is associated with neuroendocrine prostate cancer and directly suppressed by androgen receptor 2023 ·British Journal of Cancer ·Anthony Turpin, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Anne Flourens, (unknown), (unknown), Xavier Leroy, Nicolás Herranz, (unknown), Arnauld Villers, Jonathan Olivier, Hélène Touzet, Yvan de Launoit, Tian V. Tian, Martine Duterque‐Coquillaud	3
8	Risk of progression following a negative biopsy in prostate cancer active surveillance 2022 ·Prostate Cancer and Prostatic Diseases ·Kerri Beckmann, Aida Santaolalla, Mikio Sugimoto, Peter R. Carroll, José Luís Rubio, Arnauld Villers, Anders Bjartell, Todd M. Morgan, Prokar Dasgupta, Mieke Van Hemelrijck, Oussama Elhage	3
9	Predictive factors of postoperative septic complications after flexible ureteroscopy for urinary stones 2021 ·Progrès en Urologie ·(unknown), Matthias Garot, (unknown), (unknown), Arnauld Villers, Gilles Lebuffe, Christophe Decoene, (unknown), (unknown), (unknown), Gautier Marcq	5
10	Negative pre-biopsy magnetic resonance imaging and risk of significant prostate cancer: Baseline and long-term follow-up results 2020 ·European Urology Open Science ·(unknown), Joseph M. Norris, Philippe Puech, Xavier Leroy, Élodie Drumez, Arnauld Villers, Jonathan Olivier	0
11	Risk of biochemical recurrence based on extent and location of positive surgical margins after robot-assisted laparoscopic radical prostatectomy 2018 ·BMC Cancer ·Gautier Marcq, (unknown), Gerjon Hannink, (unknown), (unknown), Arnauld Villers, Mo Saffarini, (unknown)	13
12	A multicentre randomised controlled trial assessing whether MRI-targeted biopsy is non-inferior to standard transrectal ultrasound guided biopsy for the diagnosis of clinically significant prostate cancer in men without prior biopsy: a study protocol 2017 ·BMJ Open ·Veeru Kasivisvanathan, Fatima Jichi, Laurence Klotz, Arnauld Villers, Samir S. Taneja, Shonit Punwani, Alex Freeman, Mark Emberton, Caroline M. Moore	16
13	Tookad soluble (WST-11) second generation vascular targeted photodynamic therapy (VTP) for prostate cancer: Safety and feasibility 2011 ·UCL Discovery (University College London) ·Nimalan Arumainayagam, Caroline M. Moore, (unknown), SG Bown, Christine Allen, Arnauld Villers, (unknown), (unknown)	1
14	Thérapie photodynamique et cancer de la prostate 2010 ·Progrès en Urologie ·Pierre Colin, (unknown), Nacim Betrouni, A. Ouzzane, Philippe Puech, Xavier Leroy, J. Biserte, Arnauld Villers, Serge Mordon	10
15	Surgical treatment of renal cell carcinoma with right atrial thrombus: Early experience and description of a simplified technique 2007 ·International Journal of Surgery ·Thomas Modine, Stéphan Haulon, Luca Zini, Georges Fayad, Laurence Destrieux‐Garnier, Richard Azzaoui, (unknown), T. Gourlay, Arnauld Villers, Mohamed Koussa	11
16	[Recommendation for clinical practice: use of PET-FDG in cancer of the kidney, prostate, testicles, and the urinary bladder]. 2006 ·PubMed ·P. Bourguet, François Planchamp, Françoise Montravers, S. Vincendeau, F. Courbon, Véronique Edeline, (unknown), Dominique Rossi, Arnauld Villers	5
17	Bulletin de synthèse de veille 2006 Recommandations pour la pratique clinique : utilisation de la TEP-FDG dans les cancers du rein, de la prostate, du testicule et de la vessie 2006 ·Bulletin du Cancer ·P. Bourguet, François Planchamp, Françoise Montravers, S. Vincendeau, F. Courbon, Véronique Edeline, (unknown), Dominique Rossi, Arnauld Villers	4
18	Actualités sur le dépistage, le diagnostic et le traitement des cancers de prostate 2002 ·Bulletin du Cancer ·B. Chauvet, Arnauld Villers, Jean‐Louis Davin, (unknown)	3
19	Recommandations pratiques pour les prélèvements prostatiques. Les Membres du Sous-Comité Prostate du Comité de Cancerologie de l'Association Française d'Urologie. 1999 ·Annales de Pathologie ·(unknown), Annick Vieillefond, B Cochand‐Priollet, M C Dauge-Geffroy, (unknown), Marc de Fromont, A. Lesourd, M Toublanc, Nicole Berger, (unknown), Arnauld Villers	2
20	Microcarcinoma in the prostate: Its association with duct-acinar dysplasia 1991 ·Human Pathology ·John E. McNeal, Arnauld Villers, Elise A. Redwine, Fuad S. Freiha, Thomas A. Stamey	89

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact